Nuo De Pharm

Zhejiang Nuode Pharmaceutical Co., Ltd. (Nuode Pharm) is a Chinese pharmaceutical company and a wholly-owned subsidiary of Zhejiang Tianyu Pharmaceutical Co., Ltd. (Tianyu). Established in 2018 and headquartered in Taizhou, Zhejiang, the company specializes in the development, manufacturing, and commercialization of finished dosage forms (FDF), particularly generic and combination therapies. Its core therapeutic focus includes cardiovascular diseases, diabetes, respiratory health, and gastroenterology. Nuode Pharm leverages the vertical integration of its parent company, a leading global manufacturer of active pharmaceutical ingredients (APIs), to produce high-quality medications such as metformin/empagliflozin tablets and various treatments for hypertension and gastric disorders. The company is an active participant in China's bioequivalence programs and volume-based procurement, aiming to provide affordable and effective medical solutions.